Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM)

Historical Holders from Q4 2015 to Q3 2025

Symbol
AXSM on Nasdaq
CUSIP
05464T104
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
48.9M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
37.2M
Holdings value
$4.51B
% of all portfolios
0.013%
Grand Portfolio weight change
0%
Number of holders
349
Number of buys
188
Number of sells
-141
Average Value change %
0%
Average buys %
+0.002%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RTW INVESTMENTS, LP 3.1% -48.3% $177M -$164M 1.52M -48.1% RTW Investments, LP Jun 30, 2025

Institutional Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 37.2M $4.51B -$68.3M $121.45 349
2025 Q2 37.8M $3.95B +$74.1M $104.39 344
2025 Q1 37M $4.32B +$55.2M $116.63 349
2024 Q4 37.2M $3.15B -$143M $84.61 290
2024 Q3 38.3M $3.44B -$222M $89.87 279
2024 Q2 40.7M $3.28B +$196M $80.50 255
2024 Q1 38.3M $3.06B -$38.3M $79.80 253
2023 Q4 89.1K $7.09M +$1.41M $79.59 5
2023 Q3 37.6M $2.63B +$88.1M $69.89 219
2023 Q2 36.1M $2.6B +$316M $71.86 222
2023 Q1 31.9M $1.97B +$94.6M $61.68 190
2022 Q4 30M $2.31B +$390M $77.13 207
2022 Q3 24.7M $1.1B +$177M $44.62 175
2022 Q2 21.2M $813M +$86.6M $38.30 159
2022 Q1 19M $782M +$21.6M $41.39 160
2021 Q4 18.5M $698M -$17.6M $37.78 155
2021 Q3 18.6M $612M -$186M $32.96 162
2021 Q2 22.4M $1.51B -$37.4M $67.46 174
2021 Q1 22.9M $1.3B -$60M $56.62 182
2020 Q4 24M $1.95B -$4.08M $81.47 175
2020 Q3 23.6M $1.68B -$20.4M $71.25 167
2020 Q2 23.7M $1.95B +$153M $82.28 185
2020 Q1 22.7M $1.33B +$44M $58.83 157
2019 Q4 22.3M $2.3B +$376M $103.36 168
2019 Q3 18.8M $381M +$9.02M $20.24 107
2019 Q2 18.3M $470M +$100M $25.75 105
2019 Q1 14.7M $210M +$159M $14.23 63
2018 Q4 3.83M $10.8M +$479K $2.82 35
2018 Q3 3.53M $12.2M -$1.99M $3.45 33
2018 Q2 4.1M $13.1M -$306K $3.20 34
2018 Q1 4.23M $10.4M -$6.12M $2.45 35
2017 Q4 5.82M $32.6M -$1.05M $5.60 33
2017 Q3 6.01M $33.3M -$2.14M $5.55 26
2017 Q2 6.4M $35.3M -$6.15M $5.50 33
2017 Q1 7.26M $28.3M +$5.38M $3.90 46
2016 Q4 6.16M $41.6M -$1M $6.75 40
2016 Q3 6.31M $49.7M +$4.02M $7.88 36
2016 Q2 5.8M $43.7M +$3.93M $7.54 34
2016 Q1 5.26M $45.2M +$313K $8.60 17
2015 Q4 5.22M $47.7M +$47.7M $9.25 11